# ProSolus expands manufacturing capacity with second transdermal production line in Boerne

ProSolus, a subsidiary of Mission Pharmacal, installed a second transdermal production facility at Mission's Boerne, Texas location, more than doubling total transdermal product output to over 100 million patches annually.

- Type: Expansion
- Announced: 2017-04-25
- Where: Boerne, Texas, United States
- Status: completed
- Capacity: 100 million patches annually
- Products: transdermal patches
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ProSolus](https://endata.com/companies/23888.md)
- [Mission Pharmacal](https://endata.com/companies/23889.md) (partner)

## Sources

- [prosoluspharma.com](https://prosoluspharma.com/prosolus-seeks-higher-utilization-transdermal-drug-delivery-technology/), 2017-04-27: "ProSolus recently expanded its state-of-the-art commercial manufacturing capabilities by installing a second transdermal production facility as part of Mission's Boerne, Texas, manufacturing location."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.